Back

Importance of Angiopoietin-2 (Ang-2) for the transition from acute pulmonary embolism (PE) to chronic thromboembolic pulmonary hypertension (CTEPH)

29 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Best Posters session 4 - Best Posters in chronic thromboembolic pulmonary hypertension Chronic pulmonary hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Lukas Hobohm

University Medical Center of Mainz, Mainz (Germany)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor N. Novikova (Novosibirsk, RU)
Abstract Slides
Presentation thumbnail
Doctor N. Ikeda (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Doctor S. Darocha (Otwock, PL)
Abstract Slides

Access the full session

Session thumbnail
Best Posters session 4 - Best Posters in chronic thromboembolic pulmonary hypertension

The Event

Event poster

ESC Congress 2016

29 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Circulating Angiopoietin-2 (Angpt2) levels predict diagnosis of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
30 August 2024
thumbnail
Webinar
ESC Guidelines on Acute Pulmonary Embolism ? practical guidance into clinical practice. Part 2: challenges of managing PE in the long term
11 March 2021
thumbnail
Congress Presentation
Complications and time trends of ballon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
20 March 2026
thumbnail
Congress Session
Don’t forget to look right
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources